AML, ADULT
Clinical trials for AML, ADULT explained in plain language.
Never miss a new study
Get alerted when new AML, ADULT trials appear
Sign up with your email to follow new studies for AML, ADULT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cocktail targets tough leukemia mutations
Disease control Recruiting nowThis early-phase trial tests a new drug called revumenib alongside standard chemotherapy and another targeted drug (midostaurin) for adults newly diagnosed with acute myeloid leukemia (AML) that has specific genetic changes (NPM1 and FLT3 mutations). The study aims to find a safe…
Matched conditions: AML, ADULT
Phase: PHASE1 • Sponsor: Richard Stone, MD • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New hope for elderly leukemia patients: study tests gentler chemo combo
Disease control Recruiting nowThis study tests whether a newer, targeted drug combination (venetoclax plus azacitidine) works better than standard intensive chemotherapy for adults aged 55 to 75 with acute myeloid leukemia (AML). About 240 participants will be randomly assigned to one of the two treatments. T…
Matched conditions: AML, ADULT
Phase: PHASE3 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
French study tracks Ivosidenib's Real-World impact on Hard-to-Treat leukemia
Disease control Recruiting nowThis study observes 250 adults with a specific genetic subtype of acute myeloid leukemia (AML) who received the targeted drug Ivosidenib through a compassionate use program in France. Researchers will track survival and treatment response in patients receiving the drug as a first…
Matched conditions: AML, ADULT
Sponsor: French Innovative Leukemia Organisation • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New hope for hard-to-treat leukemia? early trial tests eganelisib alone and with chemo.
Disease control Recruiting nowThis early-phase study tests a new drug called eganelisib, given alone or with standard chemotherapy (cytarabine), in adults with acute myeloid leukemia (AML) or high-risk myelodysplastic syndromes (MDS) that have returned or not responded to prior treatments. The main goals are …
Matched conditions: AML, ADULT
Phase: PHASE1 • Sponsor: Stelexis BioSciences • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Blood transfusions guided by how you feel, not just lab numbers
Symptom relief Recruiting nowThis study looks at whether using a simple quality-of-life questionnaire to decide when to give blood transfusions can reduce the number of transfusions needed for people with advanced myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML) who are receiving palliative ca…
Matched conditions: AML, ADULT
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC